Enovis Corp
ENOV
Market Cap$2.27B
Close$
$-7.79
116.4% downside
Current Fair Value
116.4% downsideOvervalued by 116.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.27 Billion |
|---|---|
| Enterprise Value | $3.63 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.61 |
| Beta | 2.01 |
| Outstanding Shares | 54,855,810 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -24.65 |
|---|---|
| PEG | -2.48 |
| Price to Sales | 1.32 |
| Price to Book Ratio | 0.79 |
| Enterprise Value to Revenue | 1.81 |
| Enterprise Value to EBIT | -31.63 |
| Enterprise Value to Net Income | -31 |
| Total Debt to Enterprise | 0.38 |
| Debt to Equity | 0.42 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Enovis Corp
15,400 employees
CEO: Matthew Trerotola Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax...